OPKO Health, Inc.

Healthcare

NASDAQ:OPK · NASDAQ Global Select

Market Cap $1.07B Beta 1.49 P/E (TTM) -5.1

$1.42 -2.07%

-$0.03 today

52W Low $0.98High $1.60

Vol 1.74M · Avg 2.58M

EPS (TTM)-$0.28

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+6.77%

Period High

$1.58

Period Low

$1.10

Latest

$1.42

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dianthus Therapeutics, Inc.

NASDAQ:DNTH

$3.43B

Nektar Therapeutics

NASDAQ:NKTR

$1.16B

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

$1.14B

Xencor, Inc.

NASDAQ:XNCR

$914.17M

Pacira BioSciences, Inc.

NASDAQ:PCRX

$904.31M

Personalis, Inc.

NASDAQ:PSNL

$851.63M

Sana Biotechnology, Inc.

NASDAQ:SANA

$745.82M

Oculis Holding AG

NASDAQ:OCS

$634.01M

Claritev Corporation

NYSE:CTEV

$526.61M

LifeMD, Inc.

NASDAQ:LFMD

$227.30M

What is the latest OPK filing?

The latest filing shown is DEFA14A dated May 15, 2026.

How many recent filings does OPK have?

Intrinsic Alpha currently shows 20 recent filings for OPK.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.